Trial Profile
Evaluation of efficacy and safety of Alogliptin in type 2 diabetic patients with chronic kidney disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2013
Price :
$35
*
At a glance
- Drugs Alogliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Therapeutic Use
- 01 Dec 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 30 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 01 Jul 2012 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan